Search research articles
Contact Us
Filters
Showing results (61-70 of 246) with videos related to
Page
of 25
Sort By:
Anticancer Research
|
December 16, 2014
A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma
Pelin Cinar, Sarah M Calkins, Alan P Venook, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Predictive biomarkers in advance of a companion drug: ahead of their time?
Robin K Kelley, Chloe Atreya, Alan P Venook, et al.
The Oncologist
|
December 1, 2010
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective
Alan P Venook, Christos Papandreou, Junji Furuse, et al.
Gastrointestinal Cancer Research : GCR
|
March 31, 2009
Section I: essentials of ensuring excellence in cancer care
Richard M Goldberg, John L Marshall, Lisa A Kachnic, et al.
Gastrointestinal Cancer Research : GCR
|
March 31, 2009
Section III: Treatment of Advanced Gastrointestinal Cancers
Howard S Hochster, Eileen M O'Reilly, Jaffer A Ajani, et al.
Clinical Colorectal Cancer
|
January 28, 2020
Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence
Rebecca A Snyder, Keith Fournier, Richard Royal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 15, 2011
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer
Robin K Kelley, Stephanie L Van Bebber, Kathryn A Phillips, et al.
Cancer
|
March 23, 2011
Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect
Junjie Peng, Weiqi Sheng, Dan Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas
Andrew H Ko, Elizabeth Dito, Brian Schillinger, et al.
Cancer Investigation
|
January 9, 2008
Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study
Andrew H Ko, Elizabeth Dito, Brian Schillinger, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 246) with videos related to
Sort By:
Page
of 25
Anticancer Research
|
December 16, 2014
A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma
Pelin Cinar, Sarah M Calkins, Alan P Venook, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Predictive biomarkers in advance of a companion drug: ahead of their time?
Robin K Kelley, Chloe Atreya, Alan P Venook, et al.
The Oncologist
|
December 1, 2010
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective
Alan P Venook, Christos Papandreou, Junji Furuse, et al.
Gastrointestinal Cancer Research : GCR
|
March 31, 2009
Section I: essentials of ensuring excellence in cancer care
Richard M Goldberg, John L Marshall, Lisa A Kachnic, et al.
Gastrointestinal Cancer Research : GCR
|
March 31, 2009
Section III: Treatment of Advanced Gastrointestinal Cancers
Howard S Hochster, Eileen M O'Reilly, Jaffer A Ajani, et al.
Clinical Colorectal Cancer
|
January 28, 2020
Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence
Rebecca A Snyder, Keith Fournier, Richard Royal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 15, 2011
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer
Robin K Kelley, Stephanie L Van Bebber, Kathryn A Phillips, et al.
Cancer
|
March 23, 2011
Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect
Junjie Peng, Weiqi Sheng, Dan Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas
Andrew H Ko, Elizabeth Dito, Brian Schillinger, et al.
Cancer Investigation
|
January 9, 2008
Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study
Andrew H Ko, Elizabeth Dito, Brian Schillinger, et al.
Page
of 25